We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Following its Phase 1 investigation, the CMA has found that Theramex's proposed purchase of Femoston and Duphaston could reduce competition and choice for hormone replacement therapy treatments.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Import supply meters affected by onsite renewable electricity generation.
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
Product recall for Fitbit Ionic Smartwatch presenting a risk of burns as the battery can overheat.
Product Safety Report for Body Treat Maxitoner Skin Beautifying Milk presenting a serious chemical risk due to the presence of the chemicals hydroquinone, methylchloroisothiazolinone and methylisothiazolinone (MCI/MI).
The new vaccine from HIPRA Human Health has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
Product recall for Giro Sport Design Giro Merit Bicycle Helmet presenting a risk of injuries.
Updates from MHRA on the suspension of devices made by Silimed
The Innovative Devices Access Pathway (IDAP) pilot was launched today by the Department of Health and Social Care (DHSC), Health Technology Wales (HTW), the Medicines and Healthcare products Regulatory Agency (MHRA), the National Health Service England (NHSE), the National Institute...
Product recall for Minoti children's playsuit (M230077) presenting a high risk of entrapment and injuries.
Product Recall for VinBee Travel Mini Hair Flat Iron Ceramic Tourmaline Hair Straightener sold via Amazon presenting a high risk of electric shock.
The successful five winners of a brand new challenge from a collaboration of regulators and healthcare organisations in the UK and US have been announced today (10 January 2024). The challenge saw 25 teams of artificial intelligence and machine learning...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).